Pathogenomix Ripseq sequence-based analysis reduces the time needed to identify infectious pathogens, in pure- or poly-microbial samples, by up to 90% - and provides answers where other methods fail. Use any sequencing technology you want - Sanger or NGS - Ripseq is platform agnostic. Combined with Ripseq DB, this is complete SaaS diagnostic solution, able to identify pathogens more accurately, faster and at lower cost than current methods.